Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-756423 plus Indinavir in HIV patients failing Indinavir
NCT00002452Phase 2Completed
- Sponsor
- Merck & Co.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of L-756423 in human immunodeficiency virus infection (HIV), sponsored by Merck & Co.. Status: completed.
02
Drugs
L-756423
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002452.